For research use only. Not for therapeutic Use.
Competitive, selective, and brain penetrant NPS receptor antagonist that preferentially blocks NPS-induced ERK phosphorylation over intracellular Ca2+ or cAMP responses (IC50 values 22.1 nM, 36.5 nM, and 5.0 nM, in Ca2+, cAMP, and binding assays, respectively). NCGC84 decreases alcohol self-administration in vivo, and does not inhibit the vasopressin V1b or the endogenous purinergic receptor at concentrations up to 10 µM.
Catalog Number | I008257 |
CAS Number | 1345964-89-7 |
Molecular Formula | C29H26N2PS.Br |
Purity | ≥95% |
IUPAC Name | [2-methyl-1-[(E)-3-phenylprop-2-enyl]imidazo[1,2-a]pyridin-4-ium-3-yl]-diphenyl-sulfanylidene-λ5-phosphane;bromide |
InChI | InChI=1S/C29H26N2PS.BrH/c1-24-29(32(33,26-17-7-3-8-18-26)27-19-9-4-10-20-27)31-22-12-11-21-28(31)30(24)23-13-16-25-14-5-2-6-15-25;/h2-22H,23H2,1H3;1H/q+1;/p-1/b16-13+; |
SMILES | CC1=C([N+]2=CC=CC=C2N1C/C=C/C3=CC=CC=C3)P(=S)(C4=CC=CC=C4)C5=CC=CC=C5.[Br-] |
Reference | A. Thorsell et al. A novel brain penetrant NPS receptor antagonist, NCGC00185684, blocks alcohol-induced ERK-phosphorylation in the central amygdala and decreases operant…. J Neurosci. 2013 Jun 12;33(24):10132-42. doi: 10.1523/JNEUROSCI.4742-12.2013. |